Proteome Differences in the First- and Third-Trimester Human Placentas

被引:0
作者
Behrouz Gharesi-Fard
Jaleh Zolghadri
Eskandar Kamali-Sarvestani
机构
[1] Shiraz Medical School,Department of Immunology
[2] Shiraz University of Medical Sciences,Infertility Research Center
[3] Shiraz University of Medical Sciences,Proteomics Laboratory
[4] School of Advanced Medical Sciences and Technologies,Department of Obstetrics and Gynecology
[5] Shiraz University of Medical Sciences,Autoimmune Diseases Research Center
[6] Shiraz University of Medical Sciences,undefined
来源
Reproductive Sciences | 2015年 / 22卷
关键词
placenta; proteomics; first trimester; third trimester; mass spectrometry;
D O I
暂无
中图分类号
学科分类号
摘要
Placenta is a transient and unique pregnancy tissue that supports the fetus nutritionally and metabolically. Expression of the unique placental proteins in different stages may influence the development of the fetus as well as the pregnancy outcome. The present study aimed to compare the total placental proteome differences between the normal first- and third-trimester human placentas. In the current study, placental proteome was compared between normal first- and third-trimester placentas using 2-dimensional polyacrylamide gel electrophoresis method for separation and matrix-assisted laser desorption/ionization time-of flight mass spectrometry technique for identification of the proteins. Despite the overall similarities, comparison of the mean intensity of the protein spots between the first- and third-trimester placental proteomes revealed that 22 spots were differentially expressed (P < .05) among which 11 distinct spots were successfully identified. Of the 11 differentially expressed proteins, 4 were increased (protein disulfide isomerase, tropomyosin 4 isoform 2, enolase 1, and 78-kDa glucose-regulated protein), while the remaining 7 (actin γ1 propeptide, heat shock protein gp96, α1-antitrypsin, EF-hand domain family member D1, tubulin α1, glutathione S-transferase, and vitamin D binding protein) showed decreased expression in the placentas from the first-trimester compared to the full-term ones. In summary, the results of the present study as the first research on the comparison of the first- and third-trimester human placental proteomes introduced a group of 11 proteins with altered expression. Interestingly, some of these proteins are reported to be altered in pregnancy-related disorders.
引用
收藏
页码:462 / 468
页数:6
相关论文
共 117 条
[1]  
Cross JC(2006)Placental function in development and disease Reprod Fertil Dev 18 71-76
[2]  
Croy BA(2008)Maternal–fetal immunology Immunol Invest 37 389-394
[3]  
Than NG(2004)From basic research to clinical application of placental proteins a workshop report Placenta 25 S109-S111
[4]  
Bohn H(2006)Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome Placenta 27 869-875
[5]  
Toth P(2002)Oxygen as a regulator of cellular phenotypes in pregnancy and cancer Can. J Physiol Pharmacol 80 103-109
[6]  
Bersinger N(2005)An emerging role for comprehensive proteome analysis in human pregnancy research Reproduction 129 685-696
[7]  
Grudzinskas JG(2008)Proteomics of the human placenta: promises and realities Placenta 29 135-143
[8]  
Bischof P(2007)Proteome analysis of human placentae: pre-eclampsia versus normal pregnancy Placenta 28 676-687
[9]  
Bose P(2013)Expanded protein expression profile of human placenta using two-dimensional gel electrophoresis Placenta 34 193-196
[10]  
Kadyrov M(2003)Functional proteomics of neurokinin B in the placenta indicated a novel role in regulating cytotrophoblast antioxidant defenses Proteomics 3 2044-2051